Live Chart

O 992.4

H 992.4

L 992.4

VOL 470

Concord Biotech Overview

Days Range

Low: ₹992.40
High: ₹1,006.10
Previous Close ₹992.35
Open ₹992.40
Volume 79,862
Day’s Range ₹992.40 - ₹1,006.10
52W Range ₹900.05 - ₹1,075.00
Market Cap ₹10,482 Cr

Fundamentals of Concord Biotech

ROCE (TTM) 24.71%
P/E Ratio (TTM) 43.66
P/B Ratio 8.13
Industry P/E 31.63
Debt to Equity 0.02
ROE 18.61%
EPS (TTM) 22.69
Dividend Yield 0.68%
Book Value 123
Face Value 1

Financials of Concord Biotech

Jun 2022Mar 2023Jun 2023
Net Sales181272.59194.83
Expenses129.94157.71135.72
Profit before tax64.01123.6171.04
Operating Profit49.2691.4954.49
Net Profit49.2691.4954.49
EPS in Rs4.718.755.21

About Concord Biotech

Concord Biotech Ltd was originally incorporated as Servomed Pharmaceuticals Private Limited' at Ahmedabad, Gujarat as a Private Limited Company dated November 23, 1984, issued by the Registrar of Comp ... Read More

Parent Organisation Indian Private
Founded 1984
Managing Director NA
NSE Symbol CONCORDBIO

Peer Comparison

Stocks Market Cap (cr) Market Price (₹) 52 Week Low-High (₹)
Supriya Lifescience Ltd ₹2,244.26

279.15

0.40 (0.14%)

276.75 - 282.95
Celestial Biolabs Ltd ₹4.56

1.75

0.00 (0.00)

1.75 - 1.8
JFL Life Sciences Ltd ₹52.02

47.3

0.00 (0.00)

44 - 47.85
Procter & Gamble Health Ltd ₹8,255.43

4974.3

14.50 (0.29%)

4902.55 - 4984.35
Veerhealth Care Ltd ₹42.28

26

0.00 (0.00)

26 - 26

What's Trending

FAQs

What is the Share price of Concord Biotech (CONCORDBIO)?

Concord Biotech (CONCORDBIO) share price as of September 26, 2023, on NSE is Rs 1,002.55 (NSE) and Rs 1,002.00 (BSE) on BSE.

Can I buy Concord Biotech (CONCORDBIO) shares?

Yes, You can buy Concord Biotech (CONCORDBIO) shares by opening a Demat account with Angel One.

How do I buy Concord Biotech (CONCORDBIO) from Angel One?

Concord Biotech (CONCORDBIO) share can be brought through the following modes:
  1. Direct investment: You can buy Concord Biotech (CONCORDBIO) shares by opening a Demat account with Angel One.
  2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Concord Biotech (CONCORDBIO) shares.